Can the Routine Use of Patient-Reported Outcome Measures Improve the Delivery of Person-Centered Diabetes Care? A Review of Recent Developments and a Case Study Soren E. SkovlundTH LichtenbergN. Ejskjaer Psychosocial Aspects (SS Jaser, Section Editor) 16 August 2019 Article: 84
Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes Abu Saleh Md MoinAlexandra E. Butler Pathogenesis of Type 1 Diabetes (A Pugliese and SJ Richardson, Section Editors) Open access 10 August 2019 Article: 83
Genetic and Environmental Interaction in Type 1 Diabetes: a Relationship Between Genetic Risk Alleles and Molecular Traits of Enterovirus Infection? Marfa BlanterHelena SorkMalin Flodström-Tullberg Pathogenesis of Type 1 Diabetes (A Pugliese and SJ Richardson, Section Editors) Open access 10 August 2019 Article: 82
The Beta Cell in Type 2 Diabetes Ashley A. ChristensenMaureen Gannon Pathogenesis of Type 2 Diabetes and Insulin Resistance (M-E Patti, Section Editor) 09 August 2019 Article: 81
Exercise in Pregnant Women with Diabetes Tricia M. PetersAnne-Sophie Brazeau Diabetes and Pregnancy (M-F Hivert and CE Powe, Section Editors) 06 August 2019 Article: 80
How Recent Advances in Genomics Improve Precision Diagnosis and Personalized Care of Maturity-Onset Diabetes of the Young Martine VaxillairePhilippe FroguelAmélie Bonnefond Pediatric Type 2 and Monogenic Diabetes (O Pinhas-Hamiel, Section Editor) 05 August 2019 Article: 79
Public Health Approaches to Type 2 Diabetes Prevention: the US National Diabetes Prevention Program and Beyond Stephanie M. GrussKunthea NhimAnn Albright Diabetes Epidemiology (E Selvin and K Foti, Section Editors) Open access 05 August 2019 Article: 78
Regulation of Glucose Production in the Pathogenesis of Type 2 Diabetes Ashot SargsyanMark A. Herman Pathogenesis of Type 2 Diabetes and Insulin Resistance (M-E Patti, Section Editor) 03 August 2019 Article: 77
Liver to Pancreas Transdifferentiation Irit Meivar-LevySarah Ferber Immunology, Transplantation, and Regenerative Medicine (L Piemonti and V Sordi, Section Editors) 02 August 2019 Article: 76
Economics of Beta-Cell Replacement Therapy Cátia BandeirasAlbert J. HwaRobert A. Gabbay Economics and Policy in Diabetes (AA Baig and N Laiteerapong, Section Editors) 02 August 2019 Article: 75
Scaling Up Teleophthalmology for Diabetic Eye Screening: Opportunities for Widespread Implementation in the USA Yao LiuAlejandra Torres DiazRamsey Benkert Microvascular Complications—Retinopathy (DL Chao and G Yiu, Section Editors) 02 August 2019 Article: 74
Nutritional Supplementation for the Prevention and/or Treatment of Gestational Diabetes Mellitus Jasmine F. PlowsClare M. ReynoldsJoanna L. Stanley Diabetes and Pregnancy (M-F Hivert and CE Powe, Section Editors) 01 August 2019 Article: 73
Artificial Intelligence Screening for Diabetic Retinopathy: the Real-World Emerging Application Valentina BellemoGilbert LimDaniel Shu Wei Ting Microvascular Complications—Retinopathy (DL Chao and G Yiu, Section Editors) 31 July 2019 Article: 72
Klinefelter Syndrome and Diabetes Mark J. O’ConnorEmma A. SnyderFrances J. Hayes Other Forms of Diabetes and Its Complications (JJ Nolan and H Thabit, Section Editors) 31 July 2019 Article: 71
Risk Factors of Obesity in Veterans of Recent Conflicts: Need for Diabetes Prevention Dora Lendvai WischikCherlie Magny-NormilusRobin Whittemore Psychosocial Aspects (SS Jaser, Section Editor) 31 July 2019 Article: 70
Extracellular Vesicles in Type 1 Diabetes: Messengers and Regulators Sarita NegiAlissa K. RutmanSteven Paraskevas Pathogenesis of Type 1 Diabetes (A Pugliese and SJ Richardson, Section Editors) 31 July 2019 Article: 69
Treatment of Diabetic Macular Edema Eric J. KimWeijie V. LinChristina Y. Weng Microvascular Complications—Retinopathy (DL Chao and G Yiu, Section Editors) 29 July 2019 Article: 68
Genetics of Diabetic Retinopathy Jonathan HanLeonardo LandoDaniel L. Chao Microvascular Complications—Retinopathy (DL Chao and G Yiu, Section Editors) 29 July 2019 Article: 67
Rebuttals to “The Debate on Insulin vs. Non-insulin Use in the Hospital Setting—Continued Use of Insulin or Time to Revise the Guidelines?” Smita KumarMark E. MolitchGuillermo E. Umpierrez Rebuttal 29 July 2019 Article: 66
Debate on Insulin vs Non-insulin Use in the Hospital Setting—Is It Time to Revise the Guidelines for the Management of Inpatient Diabetes? Francisco J. PasquelMaya FayfmanGuillermo E. Umpierrez Debate 29 July 2019 Article: 65
Use of Insulin in the Inpatient Setting: Need for Continued Use Smita KumarMark E. Molitch Debate 26 July 2019 Article: 64
Commentary/Introduction for “Debate on Insulin vs. Non-insulin Use in the Hospital Setting” Articles Amisha WalliaJane Jeffrie Seley Commentary for Debate 26 July 2019 Article: 63